Member Info for Mikemine

If you and Nova think the CEO is inept, why are you still here?

The RNS is very positive yet the SP only reacts with a 4% rise. I don't know what the Market wants or expects.

Does Gamesa have no roll to play on the production side?

I hope IES are away of the state legislature that is likely to become law in Texas. If passed, it will require all generators to provide back in times of failure. This could involve battery backup and, because of VFB's shown resilience under extreme temperatures, IES would be well placed to win huge orders.

The background to this is the winter blackouts in a period of freezing temperatures in 2021 when turbines froze and the sun didn't shine. Even conventional generation struggled. Something had to be done and the new laws, which apply to existing plant as well as new, were drawn up. Hope IES are watching.

I think your last sentence said it all and it might have been a surprise to Barrington and her advisors. There was a stream of very positive news prior and at the time of the announcement which should have at least supported the SP but the Market focused on the fund raise, as ever, which couldn't have been much of a surprise, ignoring the fact that the extra funds are to be channeled in to sales and growth of revenue. It's the type of fundraise that should have been greeted with whoops of joy as it indicated that, after a long period of getting things right, VRCI are on the move towards profit.

Your view is valid to some extent but I think it's time to put that aspect behind us and be glad that there is so much positivity around the company. If they can raise enough money and reach their milestones, just think of what the MCap and SP will be in a year or so dilution or not.

What is not fully appreciated is that VRCI is on a different trajectory now. The research to enable commercialisation is done, sales have started and are ramping up and, the big one, Medicare has agreed to pay for the test with a backlog of past orders being paid for. This is not now a company that is asking for money for development and to keep the lights on. It's asking for money to expand it's proven system which will be able to lead to break even and profits beyond.

The Medicare situation is interesting because of a couple of factors. Being a government body, it is under intense scrutiny to not waste money and not make mistakes. That would lead to defensive attitude that gives a bias to negativity to change. This fosters a huge investigatory element where they are looking for reasons to reject an application. It's probably why it has taken VRCI around a year to gain acceptance. That attitude has an upside, however, in that clinicians and insurance companies can have a greater confidence in the product as they know it will have undergone a vigorous investigation.

So we have a company that has sorted out how to sell the test and is selling in growing numbers. It has acceptance from Medicare, a very good profit margin and has proved their product is better than its competitors. This has all been done on a shoestring budget so investors will know that they will be frugal with any future fund raise. They are ready to go and only need some more, probably fairly modest, money to expand to a profitable level.

I have no inside info on this and have had to use only reason to reach my conclusions. I offer my post for consideration and in no way offer it as financial advice so make your own mind up. Criticism will be welcome.

With today's trade deal news, the prospects for IES must have improved in that market. I'm not sure of IES's position before this but any residual hindrances have probably gone and customers will have more confidence to sign up knowing that there is a positive atmosphere between the 2 countries. Surprised the SP doesn't reflect that but this AIM.

I think we should think about what they are going to do with the funds. I very much doubt that they will be used just to keep the lights on.

I've heard some very derogatory remarks about the running of Lunglife and, because of the association with the overlap of certain board members, Verici. PI's don't know what is going on behind the scenes and put their own interpretations of what they are told in RNS's, coming up in Lunglife's case with the wrong scenario. Lunglife has surprised quite a few and my feeling, now they have Medicare approval, is Verici might be heading for a surprise as well. I have no inside knowledge but I've watched from afar and seen the CEO perform miracles on a shoestring. Watch that space.

Does anybody know how many tests are needed to reach breakeven?

Same story here Https://www.mercurynews.com/2025/01/16/moss-landing-power-plant-fire-evacuations-road-closures/

They are not even trying to put out the fire, just letting it burn itself out. This has got to concentrate the mind of buyers of energy storage. Just hope that VFBs don't get caught up and lumped in to the risky battery category.

Https://www.biospace.com/press-releases/fbb-biomed-signs-agreement-with-verici-dx-plc-to-offer-research-use-only-ruo-tests-to-clinicians They've just signed an agreement with FBB Biomed. No RNS yet. Could be the first of many?????

Like all these small companies in this sector, it is frustratingly hard to get traction due to the conservative nature of the client base and fear of litigation with using new stuff being used rather than available old stuff. They get to an inflexion point and suddenly growth comes almost at a rush. Is RENX there yet? Difficult to say but their revenue has increased over the quarter and there has been no hiccups recently. Cash burn seems under control and funds seem adequate. If they can get revenue to continue to rise, which mostly will go to the bottom line, they should be OK. Still risky but at least they are going in the right direction and have a credible business plan so patience will be needed here. All just my opinion of course.

Pretty good update bearing in mind this is a very small company with very limited resources. The product seems to be well received by end users and progress towards commercialisation is progressing albeit not as far as many would like. Future funding needs to strengthened but the product should propel the company and it's valuation to be much bigger than at present.

I find this pretty reliable

https://gridwatch.co.uk

£1.75p a share. Well, we can dream.

It appears that most of the nuclear power stations in the UK will be gone by 2028 leaving the Grid with a big problem of balancing all the different inputs, increasingly from renewables. As this article points out, there is an urgent need for a building programme for storage and part of that will be batteries. The Government better get a move on.

Https://www.telegraph.co.uk/business/2024/10/13/why-age-of-energy-rationing-is-looming-for-britain/ Might be behind a paywall.

I've reread this again and it looks like this could be the magic key for IES. The biggest problem thy've had so far is price competition and this allows companies to sign contracts, not on price differentials alone but with profit locked in, at any reasonable cost. I don't think the Market has realised that yet but, when Mistral starts to get orders, they will IMHO

I tried to log on this morning but a new system demands that I confirm I'm a human being first. How many cows, dogs or giraffes have tried to access this site before to make the requirement necessary I wonder.

Ticked all the milestones. The company is now gearing up for commercialisation with validation of the product in the bag. This is a success story so far but will need more cash to grow which is par for the course with this type of company at this stage of development. Any cash raised will quickly go in to commercialisation IMHO. With the contents of this RNS to show investors, it shouldn't be a problem to raise funds at a reasonable price, again IMHO. It looks a good prospect I reckon.